BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.408
-0.041 (-9.03%)
At close: Feb 21, 2025, 4:00 PM
0.407
-0.001 (-0.34%)
After-hours: Feb 21, 2025, 6:08 PM EST
BioAtla Market Cap
BioAtla has a market cap or net worth of $23.68 million as of February 21, 2025. Its market cap has decreased by -81.74% in one year.
Market Cap
23.68M
Enterprise Value
-31.59M
1-Year Change
-81.74%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $23.68M, a decrease of -95.90%. That is a compound annual growth rate of -53.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 19.73M | -30.97% |
| Dec 31, 2024 | 28.58M | -75.82% |
| Dec 29, 2023 | 118.16M | -67.45% |
| Dec 30, 2022 | 363.05M | -50.45% |
| Dec 31, 2021 | 732.64M | -35.95% |
| Dec 31, 2020 | 1.14B | 98.04% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |